BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10595760)

  • 1. Thrombosis and anticoagulation.
    Hirsh J; Weitz JI
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):118-32. PubMed ID: 10595760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of anticoagulation.
    Hoppensteadt DA; Jeske W; Walenga J; Fareed J
    Semin Respir Crit Care Med; 2008 Feb; 29(1):90-9. PubMed ID: 18302091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Where to look for progress in antithrombotic treatments?].
    Samama MM
    Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antithrombotic agents.
    Hirsh J; Weitz JI
    Lancet; 1999 Apr; 353(9162):1431-6. PubMed ID: 10227240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From the history of thrombosis prevention and treatment].
    Mahler F
    Ther Umsch; 1996 Apr; 53(4):254-7. PubMed ID: 8658346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in anti-thrombotic therapy].
    Páramo J
    An Sist Sanit Navar; 2001; 24(1):39-49. PubMed ID: 12876600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombotic therapy of acute coronary syndromes].
    Hölschermann H
    Hamostaseologie; 2007 Dec; 27(5):319-25; quiz 326-7. PubMed ID: 18060240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scientific basis for combined platelet and thrombin-directed pharmacotherapy in acute coronary syndromes.
    Becker RC
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E19-24;discussion E25-8. PubMed ID: 11156725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in anticoagulation management: the role of pharmacy.
    Smythe MA
    Ann Pharmacother; 2007 Mar; 41(3):493-5. PubMed ID: 17341523
    [No Abstract]   [Full Text] [Related]  

  • 15. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
    Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
    Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal antithrombotic treatment for percutaneous coronary intervention.
    Kadakia RA; Ferguson JJ
    Minerva Cardioangiol; 2005 Feb; 53(1):15-42. PubMed ID: 15788977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical overview of the role of platelets in hemostasis and thrombosis.
    de Gaetano G
    Haematologica; 2001 Apr; 86(4):349-56. PubMed ID: 11325638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.